{"id":16523,"date":"2026-03-25T09:19:27","date_gmt":"2026-03-25T12:19:27","guid":{"rendered":"https:\/\/www.biolabeco.com.br\/?post_type=imprensa&p=16523"},"modified":"2026-03-26T09:26:34","modified_gmt":"2026-03-26T12:26:34","slug":"biolab-points-to-opportunities-in-pharmacy-mix-management","status":"publish","type":"imprensa","link":"https:\/\/www.biolabeco.com.br\/en\/imprensa\/biolab-aponta-oportunidades-na-gestao-de-mix-em-farmacias\/","title":{"rendered":"Biolab points to opportunities in pharmacy mix management"},"content":{"rendered":"

Present on the market since 1997, the Biolab is a Brazilian pharmaceutical company with an international presence<\/a>, He works in specialties such as cardiology, dermatology, gynecology, orthopedics, gastroenterology, pediatrics, clinical medicine and the Central Nervous System (CNS).<\/p>\n\n\n\n

The group has a portfolio of around 500 products, distributed among the Biolab Farmac\u00eautica, Biolab Gen\u00e9ricos and Avert Sa\u00fade Humana business units, as well as operations focused on animal health and nutrition.<\/p>\n\n\n\n

Faced with a competitive scenario, the company has been structuring itself to sustain growth over the next few years. Among the strategic fronts is support for managing the product mix in pharmacies.<\/p>\n\n\n\n

During the Abradilan Conex\u00e3o Farma 2026 event, held in March in S\u00e3o Paulo, Biolab's commercial director, Cristiano Belolli, told the Pharmacy Guide<\/strong> the importance of assortment strategy for retail performance.<\/p>\n\n\n\n

\u201cThe great opportunity to boost the market lies in the mix. We're seeing a growing discussion about how to broaden the pharmacy mix in order to consequently increase sales and the average ticket,\u201d said the executive.<\/p>\n\n\n\n

Despite the potential, there are several challenges, including financial ones. \u201cIn the economy we live in, with high interest rates, retailers can't \u2018tie up\u2019 money in a way that harms the business,\u201d he said.<\/p>\n\n\n\n

\u201cIn this context, there are initiatives, studies and joint proposals between distributors and the pharmaceutical industry to increase the pharmacy mix in a balanced way, without jeopardizing the operating cycle, especially for smaller pharmacies.\u201d.<\/p>\n\n\n\n

According to the executive, a pharmacy works with between 7,000 and 13,000 SKUs on average. However, at the independent point of sale (POS), this number can drop to around 3,000 items.<\/p>\n\n\n\n

For Belolli, efficient assortment management is directly linked to supply and the ability to fulfill medical prescriptions, guaranteeing conversion and consumer satisfaction.<\/p>\n\n\n\n

\u201cBiolab has plans to expand its presence in more POS in a harmonious way, adding revenue to retail without compromising the operational cycle, while ensuring shopper service,\u201d he said.<\/p>\n\n\n\n

Higher conversion<\/h2>\n\n\n\n

The executive also draws attention to an opportunity that goes unnoticed by retailers. \u201cMany POSs don't know that there is a demand for various products in their region, often on their own street, and they don't have these medicines available in the store. When the consumer looks for it and can't find it, the sale migrates directly to the competitor.\u201d<\/p>\n\n\n\n

With an eye on this scenario, the pharmaceutical company conducted a pilot project in 2025 in partnership with the Brazilian Federation of Associative and Independent Pharmacy Networks (Febrafar).<\/p>\n\n\n\n

The initiative consisted of introducing three of Biolab's top-selling products into pharmacies that did not yet work with these items, and monitoring their performance over 90 days.<\/p>\n\n\n\n

According to Belolli, the results were significant: pharmacies recorded double-digit sales growth and replenished their products.<\/p>\n\n\n\n

Investments and expansion<\/h2>\n\n\n\n

With three production units in operation and a new manufacturing complex under construction, the pharmaceutical company expects to maintain double-digit growth this year.<\/p>\n\n\n\n

\u201cWe have a robust pipeline of launches for 2026,\u201d said the executive. The novelties should arrive mainly in the areas of cardiology and dermatology.<\/p>\n\n\n\n

At Abradilan Conex\u00e3o Farma 2026, for example, the company highlighted the launch of the food supplement Os Smurfs Vitaminas, from the Avert\u00ae Human Health Line, by Biolab Gen\u00e9ricos.<\/p>\n\n\n\n

Innovation remains one of the company's strategic pillars. \u201cWe have three research and development centers, including one abroad, where we carry out projects that will support our growth over the coming years,\u201d said Belolli.<\/p>\n\n\n\n

He also highlighted the restructuring of governance, which began in October 2025, with the integration of directors, founders, independent directors and the company's second generation of shareholders, with the aim of improving processes and keeping the company competitive. \u201cWe are in a very virtuous cycle, in full growth,\u201d he said.<\/p>\n\n\n\n

You can also read the article on the website: Biolab points to opportunities in pharmacy mix management<\/a><\/p>","protected":false},"featured_media":16524,"template":"","categories":[1577],"acf":[],"yoast_head":"\nBiolab aponta oportunidades na gest\u00e3o de mix em farm\u00e1cias - Biolab & Co<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.biolabeco.com.br\/en\/press\/biolab-points-to-opportunities-in-pharmacy-mix-management\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Biolab aponta oportunidades na gest\u00e3o de mix em farm\u00e1cias\" \/>\n<meta property=\"og:description\" content=\"Presente no mercado desde 1997, a Biolab \u00e9 uma ind\u00fastria farmac\u00eautica brasileira com presen\u00e7a internacional, com atua\u00e7\u00e3o em especialidades como cardiologia, dermatologia, ginecologia, ortopedia, gastroenterologia, pediatria, cl\u00ednica m\u00e9dica e Sistema Nervoso Central (SNC). O grupo re\u00fane um portf\u00f3lio com cerca de 500 produtos, distribu\u00eddos entre as unidades de neg\u00f3cios Biolab Farmac\u00eautica, Biolab Gen\u00e9ricos e Avert Sa\u00fade […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.biolabeco.com.br\/en\/press\/biolab-points-to-opportunities-in-pharmacy-mix-management\/\" \/>\n<meta property=\"og:site_name\" content=\"Biolab & Co\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-26T12:26:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.biolabeco.com.br\/wp-content\/uploads\/2026\/03\/cristiano-belolli-diretor-comercial-da-Biolab-no-abradilan-conexao-farma-2026.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"628\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.biolabeco.com.br\/imprensa\/biolab-aponta-oportunidades-na-gestao-de-mix-em-farmacias\/\",\"url\":\"https:\/\/www.biolabeco.com.br\/imprensa\/biolab-aponta-oportunidades-na-gestao-de-mix-em-farmacias\/\",\"name\":\"Biolab aponta oportunidades na gest\u00e3o de mix em farm\u00e1cias - Biolab & Co\",\"isPartOf\":{\"@id\":\"https:\/\/www.biolabeco.com.br\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.biolabeco.com.br\/imprensa\/biolab-aponta-oportunidades-na-gestao-de-mix-em-farmacias\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.biolabeco.com.br\/imprensa\/biolab-aponta-oportunidades-na-gestao-de-mix-em-farmacias\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.biolabeco.com.br\/wp-content\/uploads\/2026\/03\/cristiano-belolli-diretor-comercial-da-Biolab-no-abradilan-conexao-farma-2026.webp\",\"datePublished\":\"2026-03-25T12:19:27+00:00\",\"dateModified\":\"2026-03-26T12:26:34+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.biolabeco.com.br\/imprensa\/biolab-aponta-oportunidades-na-gestao-de-mix-em-farmacias\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.biolabeco.com.br\/imprensa\/biolab-aponta-oportunidades-na-gestao-de-mix-em-farmacias\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.biolabeco.com.br\/imprensa\/biolab-aponta-oportunidades-na-gestao-de-mix-em-farmacias\/#primaryimage\",\"url\":\"https:\/\/www.biolabeco.com.br\/wp-content\/uploads\/2026\/03\/cristiano-belolli-diretor-comercial-da-Biolab-no-abradilan-conexao-farma-2026.webp\",\"contentUrl\":\"https:\/\/www.biolabeco.com.br\/wp-content\/uploads\/2026\/03\/cristiano-belolli-diretor-comercial-da-Biolab-no-abradilan-conexao-farma-2026.webp\",\"width\":1200,\"height\":628,\"caption\":\"Cristiano Belolli, diretor comercial da Biolab, participa da ABRAFARMA 2026 e comenta sobre o mercado farmac\u00eautico\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.biolabeco.com.br\/imprensa\/biolab-aponta-oportunidades-na-gestao-de-mix-em-farmacias\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.biolabeco.com.br\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Biolab aponta oportunidades na gest\u00e3o de mix em farm\u00e1cias\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.biolabeco.com.br\/#website\",\"url\":\"https:\/\/www.biolabeco.com.br\/\",\"name\":\"Biolab\",\"description\":\"Na Biolab & Co, ci\u00eancia e cuidado caminham juntos. Saiba como promovemos sa\u00fade com responsabilidade socioambiental e tecnologia.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.biolabeco.com.br\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Biolab points to opportunities in pharmacy mix management - Biolab & Co","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.biolabeco.com.br\/en\/press\/biolab-points-to-opportunities-in-pharmacy-mix-management\/","og_locale":"en_US","og_type":"article","og_title":"Biolab aponta oportunidades na gest\u00e3o de mix em farm\u00e1cias","og_description":"Presente no mercado desde 1997, a Biolab \u00e9 uma ind\u00fastria farmac\u00eautica brasileira com presen\u00e7a internacional, com atua\u00e7\u00e3o em especialidades como cardiologia, dermatologia, ginecologia, ortopedia, gastroenterologia, pediatria, cl\u00ednica m\u00e9dica e Sistema Nervoso Central (SNC). O grupo re\u00fane um portf\u00f3lio com cerca de 500 produtos, distribu\u00eddos entre as unidades de neg\u00f3cios Biolab Farmac\u00eautica, Biolab Gen\u00e9ricos e Avert Sa\u00fade […]","og_url":"https:\/\/www.biolabeco.com.br\/en\/press\/biolab-points-to-opportunities-in-pharmacy-mix-management\/","og_site_name":"Biolab & Co","article_modified_time":"2026-03-26T12:26:34+00:00","og_image":[{"width":1200,"height":628,"url":"https:\/\/www.biolabeco.com.br\/wp-content\/uploads\/2026\/03\/cristiano-belolli-diretor-comercial-da-Biolab-no-abradilan-conexao-farma-2026.webp","type":"image\/webp"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.biolabeco.com.br\/imprensa\/biolab-aponta-oportunidades-na-gestao-de-mix-em-farmacias\/","url":"https:\/\/www.biolabeco.com.br\/imprensa\/biolab-aponta-oportunidades-na-gestao-de-mix-em-farmacias\/","name":"Biolab points to opportunities in pharmacy mix management - Biolab & Co","isPartOf":{"@id":"https:\/\/www.biolabeco.com.br\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.biolabeco.com.br\/imprensa\/biolab-aponta-oportunidades-na-gestao-de-mix-em-farmacias\/#primaryimage"},"image":{"@id":"https:\/\/www.biolabeco.com.br\/imprensa\/biolab-aponta-oportunidades-na-gestao-de-mix-em-farmacias\/#primaryimage"},"thumbnailUrl":"https:\/\/www.biolabeco.com.br\/wp-content\/uploads\/2026\/03\/cristiano-belolli-diretor-comercial-da-Biolab-no-abradilan-conexao-farma-2026.webp","datePublished":"2026-03-25T12:19:27+00:00","dateModified":"2026-03-26T12:26:34+00:00","breadcrumb":{"@id":"https:\/\/www.biolabeco.com.br\/imprensa\/biolab-aponta-oportunidades-na-gestao-de-mix-em-farmacias\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.biolabeco.com.br\/imprensa\/biolab-aponta-oportunidades-na-gestao-de-mix-em-farmacias\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.biolabeco.com.br\/imprensa\/biolab-aponta-oportunidades-na-gestao-de-mix-em-farmacias\/#primaryimage","url":"https:\/\/www.biolabeco.com.br\/wp-content\/uploads\/2026\/03\/cristiano-belolli-diretor-comercial-da-Biolab-no-abradilan-conexao-farma-2026.webp","contentUrl":"https:\/\/www.biolabeco.com.br\/wp-content\/uploads\/2026\/03\/cristiano-belolli-diretor-comercial-da-Biolab-no-abradilan-conexao-farma-2026.webp","width":1200,"height":628,"caption":"Cristiano Belolli, diretor comercial da Biolab, participa da ABRAFARMA 2026 e comenta sobre o mercado farmac\u00eautico"},{"@type":"BreadcrumbList","@id":"https:\/\/www.biolabeco.com.br\/imprensa\/biolab-aponta-oportunidades-na-gestao-de-mix-em-farmacias\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.biolabeco.com.br\/"},{"@type":"ListItem","position":2,"name":"Biolab aponta oportunidades na gest\u00e3o de mix em farm\u00e1cias"}]},{"@type":"WebSite","@id":"https:\/\/www.biolabeco.com.br\/#website","url":"https:\/\/www.biolabeco.com.br\/","name":"Biolab","description":"At Biolab & Co, science and care go hand in hand. Find out how we promote health with social and environmental responsibility and technology.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.biolabeco.com.br\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.biolabeco.com.br\/en\/wp-json\/wp\/v2\/imprensa\/16523"}],"collection":[{"href":"https:\/\/www.biolabeco.com.br\/en\/wp-json\/wp\/v2\/imprensa"}],"about":[{"href":"https:\/\/www.biolabeco.com.br\/en\/wp-json\/wp\/v2\/types\/imprensa"}],"version-history":[{"count":1,"href":"https:\/\/www.biolabeco.com.br\/en\/wp-json\/wp\/v2\/imprensa\/16523\/revisions"}],"predecessor-version":[{"id":16525,"href":"https:\/\/www.biolabeco.com.br\/en\/wp-json\/wp\/v2\/imprensa\/16523\/revisions\/16525"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.biolabeco.com.br\/en\/wp-json\/wp\/v2\/media\/16524"}],"wp:attachment":[{"href":"https:\/\/www.biolabeco.com.br\/en\/wp-json\/wp\/v2\/media?parent=16523"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.biolabeco.com.br\/en\/wp-json\/wp\/v2\/categories?post=16523"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}